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Recent twin studies highlight the astonishing impact
of non-heritable contributions to our immune health
and wellbeing. Immunologists, long familiar with
heterogeneity generated from within cells, must now
grapple with heterogeneity between and within
individuals which is present to an extraordinary degree.
The capacity to interpret and find patterns in the face
of such immune system diversity may be limited when
sampling is restricted to blood, necessitating the
development of new approaches.low heritability. In contrast, in communities in whichImmune system heterogeneity
It is a point of some embarrassment to immunologists
(and disappointment to medical insurers) that patients
cannot walk into a doctor’s surgery or pathology clinic
and receive a test to determine the health of their im-
mune systems. This is not for lack of things to measure;
indeed, the immune system, many components of which
are carried in peripheral blood, offers hundreds of cell
types and perhaps thousands of molecules that can be
monitored. Our inability to offer this service results from
a problem more fundamental than technological failure.
At its core, the issue is the immense heterogeneity and
variability in immune cells and proteins.
A study recently published in Cell by Brodin et al. [1]
attempted to determine the proportion of the variance
seen in immunological traits within a population that is
contributed by heritable factors (heritability). They mea-
sured the levels of 51 secreted factors (such as the cyto-
kines interleukin (IL)4, IL7 and interferon gamma) and
the frequencies of 95 immune cell subsets (for example,
T cells, B cells and neutrophils) in peripheral blood, as
well as 58 cellular responses to cytokine stimulation, in
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article, unless otherwise stated.twin pairs. Even monozygotic twins differed greatly from
each other in most of the assays performed, and the
authors concluded that in almost 80% of the measure-
ments, heritable factors had only a minor role, and in
almost 60%, the contribution of these factors was so low
as to be undetectable.
Peter Medawar made the point that the choice of
reference population is critical in assessing heritability
[2]. For example, in a hypothetical community in which
defects in phenylalanine hydroxylase were universal and
the use of phenylalanine rare, phenylketonuria would
effectively only exist in cases of poisoning and have
phenylalanine hydroxylase deficiency is rare and phenyl-
alanine is widely used as the artificial sweetener
aspartame, phenylketonuria occurs in almost all people
bearing the deficiency and the disease has high heritabil-
ity. In the case of Brodin’s twin study, the subjects were
healthy adults from metropolitan Palo Alto, California,
in the United States. People with the known causes of
heritable immune deficiency were excluded, as were
those with a wide range of autoimmune diseases that to-
gether affect perhaps 5% of the population. Nevertheless,
taking the data at face value, it is surprising that the her-
itability of so many immune measurements is so low,
when the heritability of immune diseases is relatively
high. For example, the heritability of type 1 diabetes,
lupus and autoimmune hypothyroidism is around 80%
[3-5]. Similarly, studies of responses to numerous child-
hood vaccines are highly correlated within twins [6]. In
contrast, Brodin et al. [1], who were looking mainly
in adults and were measuring antibody titers in re-
sponse to seasonal flu vaccination, found no evidence of
heritability.Explaining the discrepancy
So what is going on? How can immune disease be highly
heritable while measurable immune parameters are so
disparate?
Many accessible immune markers not only show het-
erogeneity between individuals, but also vary widely over
time in a single person. The normal ranges cited forCentral. This is an Open Access article distributed under the terms of the
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for most lineages, and up to tenfold for monocytes. Lon-
gitudinal studies of some cell types show either high
variation over time (for example, T regulatory cells [7]),
or very little (for example, B-cell subsets [8]). Brodin
et al. [1] examined a single time point for each subject,
raising the question of how different twins within a pair
are from each other, compared to testing the same twin
twice. To address this issue in part, Brodin et al. com-
pared variation in multiple samples collected from indi-
vidual donors over time. Of the 182 assays tested
repeatedly, for only 26 did 95% of the replicate measure-
ments fall within a third of the mean value.
The second possible explanation for the observed lack
of heritability is that the immune system is complex and
immune function is an emerging phenomenon resulting
from networks of interactions that are summated in
ways we do not yet fully understand. One of the compel-
ling conclusions of the Brodin study is that this already
complex system changes further with time through the
cumulative action of non-heritable influences. What are
these influences? A strong case is made that infection is
a major effector, as chronic cytomegalovirus (CMV)
exposure significantly altered the phenotypes of infected
versus non-infected twins. However, the changes may
also arise from stochastic processes. T- and B-cell anti-
gen receptors arise from probabilistic gene assortment
and differ between identical individuals, affecting their
immune responses [9]. Other stochastic fate decisions
recently identified for T- and B-cell responses are also
likely to be magnified in influence over time, especially if
responses are channeled through limiting numbers of
responding cells [10].
Could these time-dependent, non-heritable changes,
as reflected in blood, serve as diagnostic indicators
or predictors of immune status? Perhaps, yes. The
highly variable pre-immune patterns of naïve and
memory cell types were successfully correlated and
used to predict vaccine outcome in another study, by
Tsang et al. [8].
The third possible explanation for the high heritability
seen with immune disease, but low heritability for im-
mune blood tests, is almost trivial. The blood is not a
significant site of immune activity: the complex interac-
tions that take place between cells and cytokines occur
in lymphoid organs and in the tissues. With the excep-
tion of the acute phase response, circulating titers of
most cytokines may have limited functional impact.
Similarly, for most lymphocytes, blood is a vehicle of
recirculation, rather than a site of activation and effector
function. It is possible that we will have to accept that
the blood will always be a poor window into our im-
mune corpus, despite our recent ability to measure its
constitution in many dimensions.Wider implications
Where does this leave the dream for an immune system
‘fitness check’? Blood tests for several immune parame-
ters are already capable of detecting well-characterized
immune diseases; allergies, diabetes, lupus and immuno-
globulin deficiencies can all be diagnosed by blood tests.
In contrast, significant questions remain over the im-
portance of differences in results within normal ranges
in otherwise healthy people. The Brodin et al. study
highlights the considerable variation accumulated over a
lifetime in many peripheral blood immune parameters.
Whether this variation is necessarily informative, or even
meaningful, is not yet clear. It is clear, however, that the
implications of this discovery are challenging. Monitor-
ing the health and potential of our changing immune
systems is not going to be easy, and may never be
accurate.
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